Su, Fengting
Koeberle, Andreas http://orcid.org/0000-0001-6269-5088
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 18 July 2023
Accepted: 10 November 2023
First Online: 1 December 2023
Declarations
:
: A.K. performs contract research for Bionorica SE, which has a silibinin-containing phytopharmaceutical in their portfolio.
: For the purpose of open access, the authors have applied a CC BY public copyright licence to any author accepted manuscript version arising from this submission.